Jay S. Skyler

Companies

• SAB Biotherapeutics, Inc.Board member May 14, 2024 to now¹
• Applied Therapeutics, Inc.Board member May 13, 2019 to now²
• DexcomBoard member Jan 4, 2006 to May 22, 2023³
• Amylin PharmaceuticalsBoard member Feb 14, 2006 to Aug 10, 2012⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Dexcom DXCM40,000 shares⁵$3.4M at $86.04May 22, 2023
• ATApplied Therapeutics, Inc.0 shares⁶Feb 3, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 3, 2026U 42,500 shares of Applied Therapeutics, Inc.⁶
• Feb 3, 2026Returned to company 22,500 shares of Applied Therapeutics, Inc.⁶
• Jun 6, 2024Granted 45,000 shares of Applied Therapeutics, Inc.⁷
• Jun 6, 2023Granted 20,000 shares of Applied Therapeutics, Inc.⁸
• May 18, 2023Gift 3,876 shares of Dexcom⁵
• May 18, 2023Gift 3,876 shares of Dexcom⁵
• May 20, 2022Granted 969 shares of Dexcom⁹
• May 19, 2022Other 900 shares of Dexcom⁹
• May 19, 2022Other 900 shares of Dexcom⁹